{"id":2202,"date":"2010-11-01T06:51:00","date_gmt":"2010-11-01T05:51:00","guid":{"rendered":"http:\/\/neuropoolwp-com.beast-hosting.com\/2010\/11\/01\/fda-verweigert-neuer-diaetpille-qnexa-die-marktzulassung\/"},"modified":"2010-11-01T06:51:00","modified_gmt":"2010-11-01T05:51:00","slug":"fda-verweigert-neuer-diaetpille-qnexa-die-marktzulassung","status":"publish","type":"post","link":"https:\/\/www.neuropool.com\/en\/new\/nachrichten-neu\/fda-verweigert-neuer-diaetpille-qnexa-die-marktzulassung.html","title":{"rendered":"FDA denies marketing approval for new diet pill Qnexa"},"content":{"rendered":"<p>\u00a0<\/p>\n<p style=\"text-align: center;\"><img decoding=\"async\" alt=\"Die FDA stellt sich gegen Qnexa\" height=\"150\" width=\"200\" src=\"http:\/\/www.fair-news.de\/cmsAdmin\/uploads\/178688_thumb.jpg\" \/><\/p>\n<p>Das neue Gewichtsreduktionsmedikament Qnexa hat von der Food and Drug Administration (FDA) keine Zulassungsbewilligung erhalten. Der Hersteller dieses neuen Medikaments, Vivus Inc., hat sich zuversichtlich dazu ge\u00e4ussert, die Auflagen, die ihnen von der FDA f\u00fcr eine Zulassung gemacht wurden, erf\u00fcllen zu k\u00f6nnen.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00a0 Das neue Gewichtsreduktionsmedikament Qnexa hat von der Food and Drug Administration (FDA) keine Zulassungsbewilligung erhalten. Der Hersteller dieses neuen Medikaments, Vivus Inc., hat sich zuversichtlich dazu ge\u00e4ussert, die Auflagen, die ihnen von der FDA f\u00fcr eine Zulassung gemacht wurden, erf\u00fcllen zu k\u00f6nnen.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_fgj2wp_old_id":["1471"],"rank_math_focus_keyword":["fda verweigert neuer di\u00e4tpille qnexa die marktzulassung"],"rank_math_analytic_object_id":["2312"],"rank_math_og_content_image":["a:2:{s:5:\"check\";s:32:\"b3353d1b62afe0698876b881c61675fd\";s:6:\"images\";a:0:{}}"],"rank_math_internal_links_processed":["1"]},"categories":[33],"tags":[],"class_list":["post-2202","post","type-post","status-publish","format-standard","hentry","category-nachrichten-neu","entry"],"_links":{"self":[{"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/posts\/2202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/comments?post=2202"}],"version-history":[{"count":0,"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/posts\/2202\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/media?parent=2202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/categories?post=2202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.neuropool.com\/en\/wp-json\/wp\/v2\/tags?post=2202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}